Similar articles

• [Cardiovascular risk factors. Insights from Framingham Heart Study].

  O'Donnell CJ, Elosua R. O'Donnell CJ, et al. Rev Esp Cardiol. 2008 Mar;61(3):299-310. Rev Esp Cardiol. 2008. PMID: 18361904 Review. Spanish.
• Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into coronary heart disease (CHD) and stroke.

  van Kempen BJ, Ferket BS, Kavousi M, Leening MJ, Steyerberg EW, Ikram MA, Witteman JC, Hofman A, Franco OH, Hunink MG. van Kempen BJ, et al. Int J Cardiol. 2014 Feb 15;171(3):413-8. doi: 10.1016/j.ijcard.2013.12.036. Epub 2013 Dec 27. Int J Cardiol. 2014. PMID: 24438922
• Women and cardiovascular disease: contributions from the Framingham Heart Study.

  Murabito JM. Murabito JM. J Am Med Womens Assoc (1972). 1995 Mar-Apr;50(2):35-9, 55. J Am Med Womens Assoc (1972). 1995. PMID: 7722204 Review.
• [Calculation of the absolute cardiovascular risk in practice].

  Mayaudon H, Dupuy O, Bordier L, Sarret D, Bauduceau B. Mayaudon H, et al. Diabetes Metab. 2001 Feb;27(1):82-6. Diabetes Metab. 2001. PMID: 11240453 Review. French.
• Drinking habits and cardiovascular disease: the Framingham Study.

  Gordon T, Kannel WB. Gordon T, et al. Am Heart J. 1983 Apr;105(4):667-73. doi: 10.1016/0002-8703(83)90492-1. Am Heart J. 1983. PMID: 6837419 No abstract available.